Safety of secukinumab for the treatment of active ankylosing spondylitis.

Introduction: Secukinumab is a fully human monoclonal antibody which targets and neutralizes interleukin (IL)-17A, a cytokine that plays an important role in the pathophysiology of ankylosing spond...